Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.61M Sell
29,976
-594
-2% -$68.6K 0.54% 53
2025
Q4
$3.22M Sell
30,570
-8,760
-22% -$822K 0.42% 58
2025
Q3
$3.3M Sell
39,330
-38,258
-49% -$3.15M 0.44% 58
2025
Q2
$6.14M Sell
77,588
-11,219
-13% -$892K 0.91% 31
2025
Q1
$7.97M Buy
+88,807
New +$8.29M 1.5% 12

Other funds holding MRK

S-Bank Fund Management's MRK Position: Q1 2026 in Review

S-Bank Fund Management reduced its Merck (MRK) stake by 1.9% in Q1 2026, selling an estimated $68.6K and leaving 29,976 shares worth $3.61M. The position accounts for 0.54% of the portfolio, ranked #53.

S-Bank Fund Management first reported a position in MRK in Q1 2025 and has held it in 5 quarters since. The position peaked at $7.97M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • S-Bank Fund Management held 29,976 shares of Merck worth $3.61M as of Q1 2026.
  • S-Bank Fund Management sold 594 Merck shares in Q1 2026, an estimated $68.6K.
  • Merck made up 0.54% of S-Bank Fund Management's portfolio in Q1 2026, its #53 holding.
  • S-Bank Fund Management first reported a position in Merck in Q1 2025 and has held it in 5 quarters since.
  • S-Bank Fund Management's Merck position peaked at $7.97M in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on S-Bank Fund Management's 13F filing for Q1 2026, filed 11 May 2026.